Insider trading · Q3 2026 · CIK 1737523

BioNexus Gene Lab Corp (BGLC) insider trading.

Name: BioNexus Gene Lab Corp insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at BioNexus Gene Lab Corp reported 5 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions: 5
Purchases (P): 0
Sales (S): 0
Net shares, P minus S: 0
Insiders: 5
Last filed: 2026-08-14

Insiders

Insider	Relationship	Transactions
Low Jook Yuen	Director	1
Chong Set Fui	Officer · Chief Financial Officer	1
Bin Abdul Hamid Muhammad Azrul	Director	1
Yap Chee Keong	Director	1
Tan Lee Su-Leng	Director, Officer, TenPercentOwner · Chief Executive Officer	1

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-08-13	Low Jook Yuen	A (A)	16,129	—	17,390	Form 4
2026-08-13	Chong Set Fui	A (A)	96,774	—	96,774	Form 4
2026-08-13	Bin Abdul Hamid Muhammad Azrul	A (A)	32,258	—	32,258	Form 4
2026-08-13	Yap Chee Keong	A (A)	32,258	—	32,258	Form 4
2026-08-13	Tan Lee Su-Leng	A (A)	338,709	—	338,709	Form 4

Transaction codes in this quarter

A: 5

Get BGLC insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1737523&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · BGLC company page · BioNexus Gene Lab Corp on SEC.gov

Questions

Are insiders buying or selling BioNexus Gene Lab Corp (BGLC)?

In Q3 2026, insiders at BioNexus Gene Lab Corp reported 5 non-derivative transactions on 11 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these BioNexus Gene Lab Corp insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/bglc.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.